Novel motif:111: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:08, 9 September 2013
name: | motif111_WWAATYCGCTCC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0003230 | cardiac atrium development | 3.326871e-10 |
GO:0042088 | T-helper 1 type immune response | 3.958518e-10 |
GO:0003209 | cardiac atrium morphogenesis | 2.604969e-8 |
GO:0044258 | intestinal lipid catabolic process | 2.825286e-8 |
GO:0018350 | protein esterification | 2.825286e-8 |
GO:0016056 | rhodopsin mediated signaling pathway | 4.760697e-8 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 5.188048e-8 |
GO:0060350 | endochondral bone morphogenesis | 8.278303e-8 |
GO:0003211 | cardiac ventricle formation | 9.218040e-8 |
GO:0006289 | nucleotide-excision repair | 1.096045e-7 |
GO:0097022 | lymphocyte migration into lymph node | 1.995633e-7 |
GO:0045838 | positive regulation of membrane potential | 2.094273e-7 |
GO:0007099 | centriole replication | 2.790448e-7 |
GO:0072610 | interleukin-12 secretion | 3.556003e-7 |
GO:0002408 | myeloid dendritic cell chemotaxis | 3.556003e-7 |
GO:0009404 | toxin metabolic process | 5.400534e-7 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.724015e-7 |
GO:0018126 | protein hydroxylation | 6.425668e-7 |
GO:0003283 | atrial septum development | 1.029772e-6 |
GO:0032727 | positive regulation of interferon-alpha production | 1.109333e-6 |
GO:0032736 | positive regulation of interleukin-13 production | 1.166774e-6 |
GO:0034418 | urate biosynthetic process | 1.223740e-6 |
GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 1.260608e-6 |
GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 1.431194e-6 |
GO:0010960 | magnesium ion homeostasis | 2.268049e-6 |
GO:0046390 | ribose phosphate biosynthetic process | 3.036533e-6 |
GO:0006370 | mRNA capping | 3.810636e-6 |
GO:2000659 | regulation of interleukin-1-mediated signaling pathway | 3.909823e-6 |
GO:2000409 | positive regulation of T cell extravasation | 4.250381e-6 |
GO:0043310 | negative regulation of eosinophil degranulation | 4.250381e-6 |
GO:0035696 | monocyte extravasation | 4.250381e-6 |
GO:0035705 | T-helper 17 cell chemotaxis | 4.250381e-6 |
GO:0002831 | regulation of response to biotic stimulus | 5.432154e-6 |
GO:0003417 | growth plate cartilage development | 5.687102e-6 |
GO:0048630 | skeletal muscle tissue growth | 5.887350e-6 |
GO:0007031 | peroxisome organization | 7.099688e-6 |
GO:0034695 | response to prostaglandin E stimulus | 7.667263e-6 |
GO:0009452 | RNA capping | 9.153132e-6 |
GO:0003091 | renal water homeostasis | 9.377045e-6 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 1.027610e-5 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1.034599e-5 |
GO:0009586 | rhodopsin mediated phototransduction | 1.043604e-5 |
GO:0001824 | blastocyst development | 1.182062e-5 |
GO:0045175 | basal protein localization | 1.251930e-5 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 1.381956e-5 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.561214e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 1.620921e-5 |
GO:0060056 | mammary gland involution | 1.786715e-5 |
GO:0051298 | centrosome duplication | 1.898077e-5 |
GO:0015887 | pantothenate transmembrane transport | 2.015123e-5 |
GO:0015878 | biotin transport | 2.015123e-5 |
GO:0002832 | negative regulation of response to biotic stimulus | 2.078099e-5 |
GO:0002711 | positive regulation of T cell mediated immunity | 2.107075e-5 |
GO:0048627 | myoblast development | 2.258877e-5 |
GO:0018364 | peptidyl-glutamine methylation | 2.293982e-5 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 2.293982e-5 |
GO:0003170 | heart valve development | 2.407136e-5 |
GO:0032862 | activation of Rho GTPase activity | 2.494692e-5 |
GO:2000348 | regulation of CD40 signaling pathway | 2.807293e-5 |
GO:0030157 | pancreatic juice secretion | 3.022343e-5 |
GO:0060325 | face morphogenesis | 3.227859e-5 |
GO:0032753 | positive regulation of interleukin-4 production | 3.252402e-5 |
GO:0050935 | iridophore differentiation | 3.322698e-5 |
GO:0048937 | lateral line nerve glial cell development | 3.322698e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 3.395815e-5 |
GO:0090281 | negative regulation of calcium ion import | 3.440204e-5 |
GO:0071584 | negative regulation of zinc ion import | 3.440204e-5 |
GO:0071460 | cellular response to cell-matrix adhesion | 3.596259e-5 |
GO:0032609 | interferon-gamma production | 3.606812e-5 |
GO:0050755 | chemokine metabolic process | 3.678860e-5 |
GO:0009440 | cyanate catabolic process | 3.842175e-5 |
GO:0007602 | phototransduction | 4.068084e-5 |
GO:0042264 | peptidyl-aspartic acid hydroxylation | 4.621291e-5 |
GO:0048846 | axon extension involved in axon guidance | 4.756659e-5 |
GO:0045980 | negative regulation of nucleotide metabolic process | 4.803161e-5 |
GO:0016558 | protein import into peroxisome matrix | 5.107184e-5 |
GO:0042696 | menarche | 5.130286e-5 |
GO:0032656 | regulation of interleukin-13 production | 5.566470e-5 |
GO:0060323 | head morphogenesis | 5.973540e-5 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 6.202814e-5 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 6.202814e-5 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 6.402074e-5 |
GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process | 6.691548e-5 |
GO:0002697 | regulation of immune effector process | 6.915114e-5 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 7.064149e-5 |
GO:0006657 | CDP-choline pathway | 7.423542e-5 |
GO:0001757 | somite specification | 8.027866e-5 |
GO:0001768 | establishment of T cell polarity | 8.240303e-5 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.392676e-5 |
GO:0046825 | regulation of protein export from nucleus | 8.515818e-5 |
GO:0050847 | progesterone receptor signaling pathway | 9.113582e-5 |
GO:0021849 | neuroblast division in subventricular zone | 9.152716e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.201100e-5 |
GO:0051461 | positive regulation of corticotropin secretion | 9.858182e-5 |
GO:0032754 | positive regulation of interleukin-5 production | 9.900373e-5 |
GO:0007521 | muscle cell fate determination | 9.915283e-5 |
GO:0032649 | regulation of interferon-gamma production | 1.020677e-4 |
GO:0003179 | heart valve morphogenesis | 1.036746e-4 |
GO:0046826 | negative regulation of protein export from nucleus | 1.067283e-4 |
GO:0097039 | protein linear polyubiquitination | 1.067851e-4 |
GO:0006337 | nucleosome disassembly | 1.120486e-4 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 1.143257e-4 |
GO:0035910 | ascending aorta morphogenesis | 1.152900e-4 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 1.152900e-4 |
GO:0042095 | interferon-gamma biosynthetic process | 1.166983e-4 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.172872e-4 |
GO:0044243 | multicellular organismal catabolic process | 1.248326e-4 |
GO:0006829 | zinc ion transport | 1.256515e-4 |
GO:0042693 | muscle cell fate commitment | 1.300567e-4 |
GO:0008628 | induction of apoptosis by hormones | 1.351304e-4 |
GO:0003218 | cardiac left ventricle formation | 1.353375e-4 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.365026e-4 |
GO:0060413 | atrial septum morphogenesis | 1.366325e-4 |
GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion | 1.367605e-4 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 1.425848e-4 |
GO:0015816 | glycine transport | 1.427291e-4 |
GO:0043966 | histone H3 acetylation | 1.486649e-4 |
GO:0061037 | negative regulation of cartilage development | 1.489990e-4 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.490431e-4 |
GO:0042033 | chemokine biosynthetic process | 1.550763e-4 |
GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process | 1.550763e-4 |
GO:2000256 | positive regulation of male germ cell proliferation | 1.550763e-4 |
GO:0042231 | interleukin-13 biosynthetic process | 1.550763e-4 |
GO:0010171 | body morphogenesis | 1.728118e-4 |
GO:0055078 | sodium ion homeostasis | 1.729134e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.750599e-4 |
GO:0006625 | protein targeting to peroxisome | 1.761810e-4 |
GO:0035909 | aorta morphogenesis | 1.766956e-4 |
GO:0050892 | intestinal absorption | 1.783231e-4 |
GO:0009953 | dorsal/ventral pattern formation | 1.792089e-4 |
GO:0021542 | dentate gyrus development | 1.854259e-4 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.919567e-4 |
GO:0002407 | dendritic cell chemotaxis | 1.952146e-4 |
GO:0031960 | response to corticosteroid stimulus | 2.023193e-4 |
GO:0007589 | body fluid secretion | 2.035124e-4 |
GO:0021759 | globus pallidus development | 2.093929e-4 |
GO:0006083 | acetate metabolic process | 2.136583e-4 |
GO:0030423 | targeting of mRNA for destruction involved in RNA interference | 2.136583e-4 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 2.142027e-4 |
GO:0001922 | B-1 B cell homeostasis | 2.143588e-4 |
GO:0046058 | cAMP metabolic process | 2.234459e-4 |
GO:0007603 | phototransduction, visible light | 2.308069e-4 |
GO:0014909 | smooth muscle cell migration | 2.317974e-4 |
GO:0032615 | interleukin-12 production | 2.332619e-4 |
GO:0061043 | regulation of vascular wound healing | 2.392647e-4 |
GO:0003416 | endochondral bone growth | 2.450104e-4 |
GO:0006982 | response to lipid hydroperoxide | 2.502418e-4 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 2.612745e-4 |
GO:0050891 | multicellular organismal water homeostasis | 2.657055e-4 |
GO:0060349 | bone morphogenesis | 2.680661e-4 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 2.690998e-4 |
GO:0001825 | blastocyst formation | 2.731903e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 2.855409e-4 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 2.928764e-4 |
GO:0032660 | regulation of interleukin-17 production | 3.050643e-4 |
GO:0016191 | synaptic vesicle uncoating | 3.233265e-4 |
GO:0050434 | positive regulation of viral transcription | 3.343317e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 3.413384e-4 |
GO:0048485 | sympathetic nervous system development | 3.466748e-4 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 3.534476e-4 |
GO:0046782 | regulation of viral transcription | 3.570796e-4 |
GO:0002839 | positive regulation of immune response to tumor cell | 3.753898e-4 |
GO:0060689 | cell differentiation involved in salivary gland development | 3.890880e-4 |
GO:0007565 | female pregnancy | 3.962669e-4 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 3.972001e-4 |
GO:0051384 | response to glucocorticoid stimulus | 4.024062e-4 |
GO:0007389 | pattern specification process | 4.176860e-4 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 4.183014e-4 |
GO:0006844 | acyl carnitine transport | 4.190339e-4 |
GO:0006353 | transcription termination, DNA-dependent | 4.207014e-4 |
GO:0071481 | cellular response to X-ray | 4.411401e-4 |
GO:0035295 | tube development | 4.542593e-4 |
GO:0043574 | peroxisomal transport | 4.827721e-4 |
GO:0019693 | ribose phosphate metabolic process | 4.962242e-4 |
GO:0033159 | negative regulation of protein import into nucleus, translocation | 5.136440e-4 |
GO:0021766 | hippocampus development | 5.202335e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 5.219109e-4 |
GO:0016246 | RNA interference | 5.226293e-4 |
GO:0016082 | synaptic vesicle priming | 5.255055e-4 |
GO:0061084 | negative regulation of protein refolding | 5.483388e-4 |
GO:0061143 | alveolar primary septum development | 5.551319e-4 |
GO:0002699 | positive regulation of immune effector process | 5.574993e-4 |
GO:0007522 | visceral muscle development | 5.654677e-4 |
GO:2000345 | regulation of hepatocyte proliferation | 5.786178e-4 |
GO:0015854 | guanine transport | 5.941262e-4 |
GO:0035364 | thymine transport | 5.941262e-4 |
GO:0035344 | hypoxanthine transport | 5.941262e-4 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 5.941262e-4 |
GO:0006424 | glutamyl-tRNA aminoacylation | 5.941262e-4 |
GO:0005983 | starch catabolic process | 5.941262e-4 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.034257e-4 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 6.037979e-4 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 6.122353e-4 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 6.122353e-4 |
GO:0051083 | 'de novo' cotranslational protein folding | 6.189784e-4 |
GO:0006333 | chromatin assembly or disassembly | 6.278003e-4 |
GO:0060563 | neuroepithelial cell differentiation | 6.305105e-4 |
GO:2000009 | negative regulation of protein localization at cell surface | 6.359049e-4 |
GO:0090273 | regulation of somatostatin secretion | 6.426400e-4 |
GO:0043117 | positive regulation of vascular permeability | 6.565803e-4 |
GO:0043382 | positive regulation of memory T cell differentiation | 6.569253e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 6.594970e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 6.621576e-4 |
GO:0071299 | cellular response to vitamin A | 6.679874e-4 |
GO:0033559 | unsaturated fatty acid metabolic process | 6.695987e-4 |
GO:0009988 | cell-cell recognition | 6.707524e-4 |
GO:0030836 | positive regulation of actin filament depolymerization | 7.006179e-4 |
GO:0030299 | intestinal cholesterol absorption | 7.078851e-4 |
GO:0003205 | cardiac chamber development | 7.252053e-4 |
GO:0021764 | amygdala development | 7.441473e-4 |
GO:0002507 | tolerance induction | 7.448902e-4 |
GO:0006284 | base-excision repair | 7.535853e-4 |
GO:0051489 | regulation of filopodium assembly | 7.850729e-4 |
GO:0001822 | kidney development | 7.870746e-4 |
GO:0002920 | regulation of humoral immune response | 7.880865e-4 |
GO:0042538 | hyperosmotic salinity response | 7.981287e-4 |
GO:0032602 | chemokine production | 7.981287e-4 |
GO:0009214 | cyclic nucleotide catabolic process | 8.020045e-4 |
GO:0051182 | coenzyme transport | 8.025057e-4 |
GO:0007422 | peripheral nervous system development | 8.039113e-4 |
GO:0045136 | development of secondary sexual characteristics | 8.146353e-4 |
GO:0046543 | development of secondary female sexual characteristics | 8.184373e-4 |
GO:0048524 | positive regulation of viral reproduction | 8.234229e-4 |
GO:0006690 | icosanoid metabolic process | 8.422059e-4 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 8.719348e-4 |
GO:0048384 | retinoic acid receptor signaling pathway | 8.764651e-4 |
GO:0006198 | cAMP catabolic process | 8.798576e-4 |
GO:0006285 | base-excision repair, AP site formation | 8.880325e-4 |
GO:0031643 | positive regulation of myelination | 8.905344e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 8.911945e-4 |
GO:0002819 | regulation of adaptive immune response | 8.975900e-4 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 9.111680e-4 |
GO:0006308 | DNA catabolic process | 9.399291e-4 |
GO:0001776 | leukocyte homeostasis | 9.663088e-4 |
GO:0006325 | chromatin organization | 9.706590e-4 |
GO:0005978 | glycogen biosynthetic process | 9.930514e-4 |
GO:0045843 | negative regulation of striated muscle tissue development | 9.948717e-4 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | 1.002973e-3 |
GO:0001773 | myeloid dendritic cell activation | 1.002973e-3 |
GO:0002328 | pro-B cell differentiation | 1.009544e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.032048e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1.032048e-3 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 1.045291e-3 |
GO:0034224 | cellular response to zinc ion starvation | 1.056806e-3 |
GO:0071585 | detoxification of cadmium ion | 1.056806e-3 |
GO:0060033 | anatomical structure regression | 1.056922e-3 |
GO:0033189 | response to vitamin A | 1.068651e-3 |
GO:2000252 | negative regulation of feeding behavior | 1.080396e-3 |
GO:0070922 | small RNA loading onto RISC | 1.080396e-3 |
GO:0060209 | estrus | 1.080396e-3 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.083764e-3 |
GO:0090291 | negative regulation of osteoclast proliferation | 1.084570e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.084570e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 1.084570e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 1.084570e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 1.084570e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.084570e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.084570e-3 |
GO:0001782 | B cell homeostasis | 1.085473e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 1.090399e-3 |
GO:0043114 | regulation of vascular permeability | 1.091216e-3 |
GO:0046634 | regulation of alpha-beta T cell activation | 1.105343e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.106596e-3 |
GO:0032743 | positive regulation of interleukin-2 production | 1.110350e-3 |
GO:0071300 | cellular response to retinoic acid | 1.136203e-3 |
GO:0071954 | chemokine (C-C motif) ligand 11 production | 1.181951e-3 |
GO:2000525 | positive regulation of T cell costimulation | 1.181951e-3 |
GO:0035712 | T-helper 2 cell activation | 1.181951e-3 |
GO:0035708 | interleukin-4-dependent isotype switching to IgE isotypes | 1.181951e-3 |
GO:0002215 | defense response to nematode | 1.181951e-3 |
GO:0035709 | memory T cell activation | 1.181951e-3 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.214591e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 1.222165e-3 |
GO:2000108 | positive regulation of leukocyte apoptosis | 1.249103e-3 |
GO:0060322 | head development | 1.254835e-3 |
GO:0002885 | positive regulation of hypersensitivity | 1.282910e-3 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.329927e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 1.330043e-3 |
GO:0007379 | segment specification | 1.346333e-3 |
GO:0034199 | activation of protein kinase A activity | 1.357352e-3 |
GO:0002573 | myeloid leukocyte differentiation | 1.364007e-3 |
GO:0060430 | lung saccule development | 1.365629e-3 |
GO:0048880 | sensory system development | 1.365629e-3 |
GO:0002260 | lymphocyte homeostasis | 1.389027e-3 |
GO:0008156 | negative regulation of DNA replication | 1.392529e-3 |
GO:0051591 | response to cAMP | 1.394837e-3 |
GO:0007225 | patched ligand maturation | 1.412010e-3 |
GO:0048545 | response to steroid hormone stimulus | 1.442321e-3 |
GO:0016559 | peroxisome fission | 1.447370e-3 |
GO:0032663 | regulation of interleukin-2 production | 1.465472e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 1.494930e-3 |
GO:0002639 | positive regulation of immunoglobulin production | 1.512716e-3 |
GO:0050688 | regulation of defense response to virus | 1.517368e-3 |
GO:0051299 | centrosome separation | 1.523496e-3 |
GO:0097070 | ductus arteriosus closure | 1.528256e-3 |
GO:0032674 | regulation of interleukin-5 production | 1.561632e-3 |
GO:0060312 | regulation of blood vessel remodeling | 1.561981e-3 |
GO:0003002 | regionalization | 1.566206e-3 |
GO:0015074 | DNA integration | 1.567113e-3 |
GO:0045765 | regulation of angiogenesis | 1.596048e-3 |
GO:0003231 | cardiac ventricle development | 1.597481e-3 |
GO:0043009 | chordate embryonic development | 1.617717e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.628916e-3 |
GO:0090307 | spindle assembly involved in mitosis | 1.630987e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 1.636149e-3 |
GO:0043011 | myeloid dendritic cell differentiation | 1.656968e-3 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.656992e-3 |
GO:0001834 | trophectodermal cell proliferation | 1.684965e-3 |
GO:0046731 | passive induction of host immune response by virus | 1.714753e-3 |
GO:0070904 | transepithelial L-ascorbic acid transport | 1.726391e-3 |
GO:0003279 | cardiac septum development | 1.763105e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.782873e-3 |
GO:0051014 | actin filament severing | 1.788863e-3 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 1.800009e-3 |
GO:0015939 | pantothenate metabolic process | 1.804991e-3 |
GO:0032845 | negative regulation of homeostatic process | 1.811427e-3 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 1.840174e-3 |
GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 1.905727e-3 |
GO:0008049 | male courtship behavior | 1.920759e-3 |
GO:0010734 | negative regulation of protein glutathionylation | 1.920759e-3 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 1.978345e-3 |
GO:0032856 | activation of Ras GTPase activity | 1.992169e-3 |
GO:0072661 | protein targeting to plasma membrane | 1.992246e-3 |
GO:0042769 | DNA damage response, detection of DNA damage | 1.995503e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 2.022563e-3 |
GO:0071803 | positive regulation of podosome assembly | 2.031882e-3 |
GO:0055089 | fatty acid homeostasis | 2.031882e-3 |
GO:0051142 | positive regulation of NK T cell proliferation | 2.031882e-3 |
GO:0006707 | cholesterol catabolic process | 2.038914e-3 |
GO:0051930 | regulation of sensory perception of pain | 2.045321e-3 |
GO:0010107 | potassium ion import | 2.058648e-3 |
GO:0030431 | sleep | 2.146901e-3 |
GO:0002437 | inflammatory response to antigenic stimulus | 2.164473e-3 |
GO:0046514 | ceramide catabolic process | 2.165274e-3 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 2.173608e-3 |
GO:0044241 | lipid digestion | 2.177942e-3 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 2.181464e-3 |
GO:0003357 | noradrenergic neuron differentiation | 2.233201e-3 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 2.241710e-3 |
GO:0006983 | ER overload response | 2.259521e-3 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 2.270811e-3 |
GO:0071107 | response to parathyroid hormone stimulus | 2.270829e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 2.291259e-3 |
GO:0002250 | adaptive immune response | 2.299313e-3 |
GO:0035865 | cellular response to potassium ion | 2.322713e-3 |
GO:0034651 | cortisol biosynthetic process | 2.322713e-3 |
GO:0032342 | aldosterone biosynthetic process | 2.322713e-3 |
GO:0000717 | nucleotide-excision repair, DNA duplex unwinding | 2.322713e-3 |
GO:0060324 | face development | 2.324904e-3 |
GO:0051491 | positive regulation of filopodium assembly | 2.354243e-3 |
GO:0007079 | mitotic chromosome movement towards spindle pole | 2.422467e-3 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 2.455431e-3 |
GO:0003289 | atrial septum primum morphogenesis | 2.504461e-3 |
GO:0035117 | embryonic arm morphogenesis | 2.514337e-3 |
GO:0030324 | lung development | 2.523090e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 2.549103e-3 |
GO:0030208 | dermatan sulfate biosynthetic process | 2.603958e-3 |
GO:0002051 | osteoblast fate commitment | 2.603958e-3 |
GO:0021524 | visceral motor neuron differentiation | 2.603958e-3 |
GO:0002922 | positive regulation of humoral immune response | 2.623046e-3 |
GO:2000427 | positive regulation of apoptotic cell clearance | 2.663535e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.672657e-3 |
GO:0048536 | spleen development | 2.678528e-3 |
GO:0007611 | learning or memory | 2.682594e-3 |
GO:0071731 | response to nitric oxide | 2.700377e-3 |
GO:0010226 | response to lithium ion | 2.770877e-3 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.803473e-3 |
GO:0015993 | molecular hydrogen transport | 2.805213e-3 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 2.819933e-3 |
GO:0051412 | response to corticosterone stimulus | 2.835891e-3 |
GO:0060591 | chondroblast differentiation | 2.863881e-3 |
GO:0046521 | sphingoid catabolic process | 2.908562e-3 |
GO:0022600 | digestive system process | 2.925566e-3 |
GO:0035418 | protein localization to synapse | 2.941660e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 2.941660e-3 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 2.952922e-3 |
GO:0032526 | response to retinoic acid | 2.964755e-3 |
GO:0046069 | cGMP catabolic process | 2.978513e-3 |
GO:0002520 | immune system development | 2.985171e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 2.991459e-3 |
GO:0019369 | arachidonic acid metabolic process | 3.011903e-3 |
GO:0007638 | mechanosensory behavior | 3.025518e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.072224e-3 |
GO:0032205 | negative regulation of telomere maintenance | 3.078690e-3 |
GO:0007631 | feeding behavior | 3.125200e-3 |
GO:0007567 | parturition | 3.125264e-3 |
GO:0003206 | cardiac chamber morphogenesis | 3.146422e-3 |
GO:0033504 | floor plate development | 3.167132e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 3.168391e-3 |
GO:0009113 | purine base biosynthetic process | 3.179546e-3 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 3.182987e-3 |
GO:0008039 | synaptic target recognition | 3.229146e-3 |
GO:2000171 | negative regulation of dendrite development | 3.276578e-3 |
GO:0071577 | zinc ion transmembrane transport | 3.284207e-3 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 3.292727e-3 |
GO:0001957 | intramembranous ossification | 3.298742e-3 |
GO:0008033 | tRNA processing | 3.306649e-3 |
GO:0019322 | pentose biosynthetic process | 3.337825e-3 |
GO:0006268 | DNA unwinding involved in replication | 3.337825e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 3.353947e-3 |
GO:0006399 | tRNA metabolic process | 3.360600e-3 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.400366e-3 |
GO:0090231 | regulation of spindle checkpoint | 3.415645e-3 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 3.471411e-3 |
GO:0044236 | multicellular organismal metabolic process | 3.538897e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 3.547104e-3 |
GO:0015742 | alpha-ketoglutarate transport | 3.547104e-3 |
GO:0016568 | chromatin modification | 3.573463e-3 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 3.588439e-3 |
GO:0045063 | T-helper 1 cell differentiation | 3.600164e-3 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 3.614667e-3 |
GO:0002883 | regulation of hypersensitivity | 3.617884e-3 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 3.651277e-3 |
GO:0051594 | detection of glucose | 3.651277e-3 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 3.709548e-3 |
GO:0033131 | regulation of glucokinase activity | 3.845001e-3 |
GO:0061038 | uterus morphogenesis | 3.871659e-3 |
GO:0035565 | regulation of pronephros size | 3.896679e-3 |
GO:0039020 | pronephric nephron tubule development | 3.896679e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 3.896679e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 4.234048e-3 |
GO:0043932 | ossification involved in bone remodeling | 4.234048e-3 |
GO:0050792 | regulation of viral reproduction | 4.262462e-3 |
GO:0051350 | negative regulation of lyase activity | 4.318576e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 4.336737e-3 |
GO:0043500 | muscle adaptation | 4.363933e-3 |
GO:0008360 | regulation of cell shape | 4.371362e-3 |
GO:0009436 | glyoxylate catabolic process | 4.423634e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 4.433229e-3 |
GO:0006927 | transformed cell apoptosis | 4.494044e-3 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 4.494044e-3 |
GO:0014009 | glial cell proliferation | 4.540491e-3 |
GO:0030323 | respiratory tube development | 4.558090e-3 |
GO:0006479 | protein methylation | 4.603975e-3 |
GO:0071415 | cellular response to purine-containing compound | 4.670341e-3 |
GO:0030422 | production of siRNA involved in RNA interference | 4.706950e-3 |
GO:0003017 | lymph circulation | 4.706950e-3 |
GO:2000111 | positive regulation of macrophage apoptosis | 4.732870e-3 |
GO:0009449 | gamma-aminobutyric acid biosynthetic process | 4.746952e-3 |
GO:0003184 | pulmonary valve morphogenesis | 4.746952e-3 |
GO:0003139 | secondary heart field specification | 4.750641e-3 |
GO:0070646 | protein modification by small protein removal | 4.770194e-3 |
GO:0007512 | adult heart development | 4.878486e-3 |
GO:0016339 | calcium-dependent cell-cell adhesion | 4.902622e-3 |
GO:0006281 | DNA repair | 4.938422e-3 |
GO:0042255 | ribosome assembly | 4.942893e-3 |
GO:0045654 | positive regulation of megakaryocyte differentiation | 4.950794e-3 |
GO:0009612 | response to mechanical stimulus | 4.965973e-3 |
GO:0006351 | transcription, DNA-dependent | 5.008837e-3 |
GO:2000035 | regulation of stem cell division | 5.040904e-3 |
GO:0001958 | endochondral ossification | 5.062397e-3 |
GO:0006014 | D-ribose metabolic process | 5.068105e-3 |
GO:0048484 | enteric nervous system development | 5.104657e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 5.126086e-3 |
GO:0021517 | ventral spinal cord development | 5.165957e-3 |
GO:0043900 | regulation of multi-organism process | 5.194383e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 5.198495e-3 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 5.232253e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 5.237668e-3 |
GO:0009880 | embryonic pattern specification | 5.406406e-3 |
GO:0031223 | auditory behavior | 5.469605e-3 |
GO:0048534 | hemopoietic or lymphoid organ development | 5.480925e-3 |
GO:0042093 | T-helper cell differentiation | 5.535670e-3 |
GO:0032700 | negative regulation of interleukin-17 production | 5.535670e-3 |
GO:0001569 | patterning of blood vessels | 5.543595e-3 |
GO:0046060 | dATP metabolic process | 5.557184e-3 |
GO:0060005 | vestibular reflex | 5.578632e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 5.609532e-3 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 5.637579e-3 |
GO:0060348 | bone development | 5.667160e-3 |
GO:0070536 | protein K63-linked deubiquitination | 5.730548e-3 |
GO:0048935 | peripheral nervous system neuron development | 5.759887e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.764103e-3 |
GO:0016046 | detection of fungus | 5.764103e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 5.764103e-3 |
GO:0016579 | protein deubiquitination | 5.835935e-3 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 5.848189e-3 |
GO:0042256 | mature ribosome assembly | 5.848189e-3 |
GO:0043615 | astrocyte cell migration | 6.030833e-3 |
GO:0071824 | protein-DNA complex subunit organization | 6.069592e-3 |
GO:0071295 | cellular response to vitamin | 6.107761e-3 |
GO:0030862 | positive regulation of polarized epithelial cell differentiation | 6.150894e-3 |
GO:0034728 | nucleosome organization | 6.156250e-3 |
GO:0009451 | RNA modification | 6.183547e-3 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 6.188208e-3 |
GO:0072001 | renal system development | 6.195356e-3 |
GO:0009187 | cyclic nucleotide metabolic process | 6.199078e-3 |
GO:0050691 | regulation of defense response to virus by host | 6.207292e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 6.207938e-3 |
GO:0007194 | negative regulation of adenylate cyclase activity | 6.237931e-3 |
GO:0032740 | positive regulation of interleukin-17 production | 6.246202e-3 |
GO:0060465 | pharynx development | 6.272067e-3 |
GO:0043148 | mitotic spindle stabilization | 6.272067e-3 |
GO:0034378 | chylomicron assembly | 6.272067e-3 |
GO:0007612 | learning | 6.356947e-3 |
GO:0009651 | response to salt stress | 6.408621e-3 |
GO:0014912 | negative regulation of smooth muscle cell migration | 6.429656e-3 |
GO:0046323 | glucose import | 6.481607e-3 |
GO:0045008 | depyrimidination | 6.481607e-3 |
GO:0033133 | positive regulation of glucokinase activity | 6.481607e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0072178 | nephric duct morphogenesis | 4.313148e-13 |
GO:0072176 | nephric duct development | 6.687174e-12 |
GO:0072179 | nephric duct formation | 9.242627e-11 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 9.846018e-11 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 2.233295e-10 |
GO:0090185 | negative regulation of kidney development | 2.253105e-10 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.853178e-10 |
GO:0016579 | protein deubiquitination | 7.191764e-10 |
GO:0048568 | embryonic organ development | 9.069764e-10 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 2.482582e-9 |
GO:0048389 | intermediate mesoderm development | 2.482582e-9 |
GO:0007501 | mesodermal cell fate specification | 6.309232e-9 |
GO:0070646 | protein modification by small protein removal | 7.128739e-9 |
GO:0003382 | epithelial cell morphogenesis | 1.201655e-8 |
GO:0048706 | embryonic skeletal system development | 1.249430e-8 |
GO:0001823 | mesonephros development | 1.392039e-8 |
GO:0051093 | negative regulation of developmental process | 1.628801e-8 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.976387e-8 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 2.383261e-8 |
GO:0000281 | cytokinesis after mitosis | 2.605481e-8 |
GO:0001710 | mesodermal cell fate commitment | 3.583503e-8 |
GO:0019255 | glucose 1-phosphate metabolic process | 5.590830e-8 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 5.725087e-8 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 6.568497e-8 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.102402e-8 |
GO:0072189 | ureter development | 8.692644e-8 |
GO:0090183 | regulation of kidney development | 9.173434e-8 |
GO:0060548 | negative regulation of cell death | 9.534729e-8 |
GO:0072215 | regulation of metanephros development | 1.145278e-7 |
GO:0072078 | nephron tubule morphogenesis | 1.537420e-7 |
GO:0043066 | negative regulation of apoptosis | 1.690161e-7 |
GO:0071360 | cellular response to exogenous dsRNA | 1.991573e-7 |
GO:0048793 | pronephros development | 2.846198e-7 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 2.966754e-7 |
GO:0043583 | ear development | 3.028755e-7 |
GO:0043069 | negative regulation of programmed cell death | 3.248332e-7 |
GO:0072172 | mesonephric tubule formation | 3.457172e-7 |
GO:0007423 | sensory organ development | 3.889391e-7 |
GO:0032649 | regulation of interferon-gamma production | 4.305120e-7 |
GO:0042421 | norepinephrine biosynthetic process | 5.153295e-7 |
GO:0031929 | TOR signaling cascade | 5.657605e-7 |
GO:0072171 | mesonephric tubule morphogenesis | 5.967274e-7 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 6.031643e-7 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 6.084213e-7 |
GO:0072080 | nephron tubule development | 7.208975e-7 |
GO:0010604 | positive regulation of macromolecule metabolic process | 7.438275e-7 |
GO:0070167 | regulation of biomineral tissue development | 1.080574e-6 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 1.164617e-6 |
GO:0051249 | regulation of lymphocyte activation | 1.201410e-6 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 1.249816e-6 |
GO:0043330 | response to exogenous dsRNA | 1.250284e-6 |
GO:0018924 | mandelate metabolic process | 1.303452e-6 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 1.322768e-6 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.380792e-6 |
GO:0060272 | embryonic skeletal joint morphogenesis | 1.447361e-6 |
GO:0045596 | negative regulation of cell differentiation | 1.593324e-6 |
GO:0010159 | specification of organ position | 1.903475e-6 |
GO:0072190 | ureter urothelium development | 1.929583e-6 |
GO:0051241 | negative regulation of multicellular organismal process | 2.019951e-6 |
GO:0030500 | regulation of bone mineralization | 2.101672e-6 |
GO:0061333 | renal tubule morphogenesis | 2.138288e-6 |
GO:0001822 | kidney development | 2.514767e-6 |
GO:2000611 | positive regulation of thyroid hormone generation | 2.599631e-6 |
GO:0051496 | positive regulation of stress fiber assembly | 2.662602e-6 |
GO:0009893 | positive regulation of metabolic process | 2.862273e-6 |
GO:0031325 | positive regulation of cellular metabolic process | 3.060177e-6 |
GO:0034728 | nucleosome organization | 3.119696e-6 |
GO:0043201 | response to leucine | 3.235873e-6 |
GO:0072498 | embryonic skeletal joint development | 3.301250e-6 |
GO:0001886 | endothelial cell morphogenesis | 3.564697e-6 |
GO:0072197 | ureter morphogenesis | 3.572713e-6 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 3.764522e-6 |
GO:0003158 | endothelium development | 4.313207e-6 |
GO:0048562 | embryonic organ morphogenesis | 4.521627e-6 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 4.655230e-6 |
GO:0061326 | renal tubule development | 4.727162e-6 |
GO:0051026 | chiasma assembly | 4.839637e-6 |
GO:2000826 | regulation of heart morphogenesis | 5.224334e-6 |
GO:0072202 | cell differentiation involved in metanephros development | 5.228694e-6 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5.710662e-6 |
GO:0046324 | regulation of glucose import | 6.383453e-6 |
GO:0009889 | regulation of biosynthetic process | 7.125498e-6 |
GO:0072001 | renal system development | 7.486739e-6 |
GO:0072044 | collecting duct development | 7.848507e-6 |
GO:0035307 | positive regulation of protein dephosphorylation | 8.397366e-6 |
GO:0050953 | sensory perception of light stimulus | 9.042044e-6 |
GO:0031326 | regulation of cellular biosynthetic process | 9.464831e-6 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 9.508769e-6 |
GO:0060993 | kidney morphogenesis | 9.754367e-6 |
GO:0072141 | renal interstitial cell development | 1.006325e-5 |
GO:0030421 | defecation | 1.015522e-5 |
GO:0072259 | metanephric interstitial cell development | 1.021944e-5 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 1.021944e-5 |
GO:0072208 | metanephric smooth muscle tissue development | 1.021944e-5 |
GO:0072184 | renal vesicle progenitor cell differentiation | 1.021944e-5 |
GO:0072169 | specification of posterior mesonephric tubule identity | 1.021944e-5 |
GO:0072168 | specification of anterior mesonephric tubule identity | 1.021944e-5 |
GO:0035306 | positive regulation of dephosphorylation | 1.047117e-5 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1.061655e-5 |
GO:0001819 | positive regulation of cytokine production | 1.069990e-5 |
GO:0048483 | autonomic nervous system development | 1.148552e-5 |
GO:0003279 | cardiac septum development | 1.192007e-5 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.199690e-5 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.231385e-5 |
GO:0035564 | regulation of kidney size | 1.258231e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.295867e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.329629e-5 |
GO:0007162 | negative regulation of cell adhesion | 1.344576e-5 |
GO:0010092 | specification of organ identity | 1.351781e-5 |
GO:0007601 | visual perception | 1.358279e-5 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 1.375580e-5 |
GO:0043526 | neuroprotection | 1.387629e-5 |
GO:0003281 | ventricular septum development | 1.486942e-5 |
GO:0034374 | low-density lipoprotein particle remodeling | 1.676330e-5 |
GO:0061005 | cell differentiation involved in kidney development | 1.705592e-5 |
GO:0072088 | nephron epithelium morphogenesis | 1.817160e-5 |
GO:2000106 | regulation of leukocyte apoptosis | 1.840691e-5 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 1.902556e-5 |
GO:0007379 | segment specification | 1.916614e-5 |
GO:0051252 | regulation of RNA metabolic process | 2.078450e-5 |
GO:2000351 | regulation of endothelial cell apoptosis | 2.185052e-5 |
GO:0060695 | negative regulation of cholesterol transporter activity | 2.333533e-5 |
GO:0015759 | beta-glucoside transport | 2.333533e-5 |
GO:0018027 | peptidyl-lysine dimethylation | 2.333836e-5 |
GO:0048523 | negative regulation of cellular process | 2.341160e-5 |
GO:0051492 | regulation of stress fiber assembly | 2.353528e-5 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.378063e-5 |
GO:0072079 | nephron tubule formation | 2.480492e-5 |
GO:2000664 | positive regulation of interleukin-5 secretion | 2.484213e-5 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 2.484213e-5 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 2.484213e-5 |
GO:2000667 | positive regulation of interleukin-13 secretion | 2.484213e-5 |
GO:0001806 | type IV hypersensitivity | 2.484213e-5 |
GO:0021568 | rhombomere 2 development | 2.484213e-5 |
GO:0060374 | mast cell differentiation | 2.484213e-5 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 2.484213e-5 |
GO:0001958 | endochondral ossification | 2.591570e-5 |
GO:0055091 | phospholipid homeostasis | 2.667044e-5 |
GO:0002634 | regulation of germinal center formation | 2.709942e-5 |
GO:0072207 | metanephric epithelium development | 2.771868e-5 |
GO:0003215 | cardiac right ventricle morphogenesis | 2.803217e-5 |
GO:0048332 | mesoderm morphogenesis | 2.814586e-5 |
GO:0032703 | negative regulation of interleukin-2 production | 2.815329e-5 |
GO:0071173 | spindle assembly checkpoint | 3.144452e-5 |
GO:0048839 | inner ear development | 3.159877e-5 |
GO:0072009 | nephron epithelium development | 3.173877e-5 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.177916e-5 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.177916e-5 |
GO:0035304 | regulation of protein dephosphorylation | 3.309656e-5 |
GO:0048641 | regulation of skeletal muscle tissue development | 3.314652e-5 |
GO:0032715 | negative regulation of interleukin-6 production | 3.324845e-5 |
GO:0072177 | mesonephric duct development | 3.456114e-5 |
GO:0045581 | negative regulation of T cell differentiation | 3.573513e-5 |
GO:0060536 | cartilage morphogenesis | 3.736071e-5 |
GO:0043496 | regulation of protein homodimerization activity | 3.759123e-5 |
GO:0002456 | T cell mediated immunity | 4.259580e-5 |
GO:0006551 | leucine metabolic process | 4.276693e-5 |
GO:0051254 | positive regulation of RNA metabolic process | 4.386785e-5 |
GO:0016191 | synaptic vesicle uncoating | 4.456359e-5 |
GO:0003170 | heart valve development | 4.488740e-5 |
GO:0051250 | negative regulation of lymphocyte activation | 4.826818e-5 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 4.884561e-5 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 4.884561e-5 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 4.884561e-5 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 4.884561e-5 |
GO:0072192 | ureter epithelial cell differentiation | 4.884561e-5 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 4.884561e-5 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 4.884561e-5 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 4.884561e-5 |
GO:0090194 | negative regulation of glomerulus development | 4.884561e-5 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 4.884561e-5 |
GO:0060503 | bud dilation involved in lung branching | 4.884561e-5 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 4.884561e-5 |
GO:0007500 | mesodermal cell fate determination | 4.884561e-5 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 4.884561e-5 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 4.884561e-5 |
GO:0048392 | intermediate mesodermal cell differentiation | 4.884561e-5 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 4.884561e-5 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 4.884561e-5 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 4.884561e-5 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 4.884561e-5 |
GO:0072282 | metanephric nephron tubule morphogenesis | 5.018812e-5 |
GO:0045737 | positive regulation of cyclin-dependent protein kinase activity | 5.203024e-5 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 5.283478e-5 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 5.319933e-5 |
GO:2000647 | negative regulation of stem cell proliferation | 5.362217e-5 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 5.362217e-5 |
GO:0010839 | negative regulation of keratinocyte proliferation | 5.362217e-5 |
GO:0035921 | desmosome disassembly | 5.362217e-5 |
GO:0072162 | metanephric mesenchymal cell differentiation | 5.566254e-5 |
GO:0043331 | response to dsRNA | 5.703320e-5 |
GO:0045580 | regulation of T cell differentiation | 5.954192e-5 |
GO:0051276 | chromosome organization | 5.996903e-5 |
GO:0009620 | response to fungus | 6.037770e-5 |
GO:0072003 | kidney rudiment formation | 6.095109e-5 |
GO:0001656 | metanephros development | 6.229338e-5 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 6.433931e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.525241e-5 |
GO:0007252 | I-kappaB phosphorylation | 6.572058e-5 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6.735209e-5 |
GO:0035303 | regulation of dephosphorylation | 6.747600e-5 |
GO:0072073 | kidney epithelium development | 6.781908e-5 |
GO:0071715 | icosanoid transport | 6.841583e-5 |
GO:0030279 | negative regulation of ossification | 7.410386e-5 |
GO:0072170 | metanephric tubule development | 7.518919e-5 |
GO:0072224 | metanephric glomerulus development | 7.752632e-5 |
GO:0006323 | DNA packaging | 7.757723e-5 |
GO:0002118 | aggressive behavior | 7.838373e-5 |
GO:0043009 | chordate embryonic development | 7.886544e-5 |
GO:0071874 | cellular response to norepinephrine stimulus | 8.009602e-5 |
GO:0002250 | adaptive immune response | 8.020922e-5 |
GO:0050865 | regulation of cell activation | 8.100984e-5 |
GO:0032774 | RNA biosynthetic process | 8.191694e-5 |
GO:0003231 | cardiac ventricle development | 8.253413e-5 |
GO:0072205 | metanephric collecting duct development | 8.355760e-5 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 8.425640e-5 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.456397e-5 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 8.456397e-5 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 8.456397e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 8.456397e-5 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 8.456397e-5 |
GO:0009891 | positive regulation of biosynthetic process | 8.460140e-5 |
GO:0021532 | neural tube patterning | 8.686482e-5 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 8.690915e-5 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 8.732195e-5 |
GO:0031328 | positive regulation of cellular biosynthetic process | 8.854415e-5 |
GO:0001709 | cell fate determination | 8.922754e-5 |
GO:0071480 | cellular response to gamma radiation | 8.949763e-5 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 9.020071e-5 |
GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 9.474933e-5 |
GO:0071359 | cellular response to dsRNA | 9.524850e-5 |
GO:0032233 | positive regulation of actin filament bundle assembly | 9.592184e-5 |
GO:0006351 | transcription, DNA-dependent | 9.631132e-5 |
GO:0035566 | regulation of metanephros size | 9.780877e-5 |
GO:0000103 | sulfate assimilation | 1.037543e-4 |
GO:0072107 | positive regulation of ureteric bud formation | 1.046469e-4 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 1.078155e-4 |
GO:0070168 | negative regulation of biomineral tissue development | 1.101502e-4 |
GO:0002694 | regulation of leukocyte activation | 1.125989e-4 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 1.139467e-4 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.167328e-4 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.194133e-4 |
GO:0003179 | heart valve morphogenesis | 1.194133e-4 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 1.217560e-4 |
GO:0009792 | embryo development ending in birth or egg hatching | 1.238105e-4 |
GO:0001818 | negative regulation of cytokine production | 1.276324e-4 |
GO:0045911 | positive regulation of DNA recombination | 1.294604e-4 |
GO:0003211 | cardiac ventricle formation | 1.302757e-4 |
GO:0072234 | metanephric nephron tubule development | 1.309168e-4 |
GO:0060231 | mesenchymal to epithelial transition | 1.309168e-4 |
GO:0032331 | negative regulation of chondrocyte differentiation | 1.387200e-4 |
GO:0006334 | nucleosome assembly | 1.397146e-4 |
GO:0031954 | positive regulation of protein autophosphorylation | 1.416674e-4 |
GO:0030502 | negative regulation of bone mineralization | 1.422733e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 1.436778e-4 |
GO:0002287 | alpha-beta T cell activation involved in immune response | 1.444262e-4 |
GO:0003205 | cardiac chamber development | 1.457173e-4 |
GO:0045446 | endothelial cell differentiation | 1.476137e-4 |
GO:0097022 | lymphocyte migration into lymph node | 1.477026e-4 |
GO:0072610 | interleukin-12 secretion | 1.477026e-4 |
GO:0014043 | negative regulation of neuron maturation | 1.479505e-4 |
GO:0071599 | otic vesicle development | 1.496675e-4 |
GO:0061154 | endothelial tube morphogenesis | 1.524280e-4 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1.524280e-4 |
GO:0051453 | regulation of intracellular pH | 1.541050e-4 |
GO:0060363 | cranial suture morphogenesis | 1.573212e-4 |
GO:0071824 | protein-DNA complex subunit organization | 1.573845e-4 |
GO:0050482 | arachidonic acid secretion | 1.574338e-4 |
GO:0031577 | spindle checkpoint | 1.579999e-4 |
GO:0042471 | ear morphogenesis | 1.589181e-4 |
GO:0010628 | positive regulation of gene expression | 1.627120e-4 |
GO:0002320 | lymphoid progenitor cell differentiation | 1.680127e-4 |
GO:0010941 | regulation of cell death | 1.685791e-4 |
GO:0042415 | norepinephrine metabolic process | 1.687012e-4 |
GO:0042946 | glucoside transport | 1.724905e-4 |
GO:0035990 | tendon cell differentiation | 1.724905e-4 |
GO:0033128 | negative regulation of histone phosphorylation | 1.724905e-4 |
GO:0046717 | acid secretion | 1.755108e-4 |
GO:0072017 | distal tubule development | 1.783437e-4 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 1.800788e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.840775e-4 |
GO:0050866 | negative regulation of cell activation | 1.855991e-4 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 1.889223e-4 |
GO:0035993 | deltoid tuberosity development | 1.917548e-4 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.946011e-4 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.946011e-4 |
GO:0039003 | pronephric field specification | 1.946011e-4 |
GO:0021542 | dentate gyrus development | 1.966320e-4 |
GO:0072180 | mesonephric duct morphogenesis | 2.024834e-4 |
GO:0001885 | endothelial cell development | 2.153042e-4 |
GO:0090304 | nucleic acid metabolic process | 2.223965e-4 |
GO:0030856 | regulation of epithelial cell differentiation | 2.227874e-4 |
GO:0072164 | mesonephric tubule development | 2.275768e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 2.333703e-4 |
GO:0032963 | collagen metabolic process | 2.344053e-4 |
GO:0051216 | cartilage development | 2.364107e-4 |
GO:0008285 | negative regulation of cell proliferation | 2.365291e-4 |
GO:0097026 | dendritic cell dendrite assembly | 2.438936e-4 |
GO:0090074 | negative regulation of protein homodimerization activity | 2.438936e-4 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | 2.447125e-4 |
GO:0045843 | negative regulation of striated muscle tissue development | 2.455997e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.492376e-4 |
GO:0042268 | regulation of cytolysis | 2.569135e-4 |
GO:0001817 | regulation of cytokine production | 2.573248e-4 |
GO:0032663 | regulation of interleukin-2 production | 2.611118e-4 |
GO:0032743 | positive regulation of interleukin-2 production | 2.723326e-4 |
GO:0090192 | regulation of glomerulus development | 2.736969e-4 |
GO:0032782 | bile acid secretion | 2.739184e-4 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 2.739184e-4 |
GO:0003096 | renal sodium ion transport | 2.739184e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.784279e-4 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 2.784279e-4 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 2.784279e-4 |
GO:0050868 | negative regulation of T cell activation | 2.786939e-4 |
GO:0003207 | cardiac chamber formation | 2.837437e-4 |
GO:0007129 | synapsis | 2.879141e-4 |
GO:0045839 | negative regulation of mitosis | 2.907881e-4 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 2.919238e-4 |
GO:0046326 | positive regulation of glucose import | 2.932708e-4 |
GO:0072028 | nephron morphogenesis | 2.971899e-4 |
GO:0072539 | T-helper 17 cell differentiation | 2.975674e-4 |
GO:0030221 | basophil differentiation | 2.975674e-4 |
GO:0072210 | metanephric nephron development | 3.009482e-4 |
GO:0033205 | cell cycle cytokinesis | 3.087965e-4 |
GO:0002695 | negative regulation of leukocyte activation | 3.280721e-4 |
GO:0030857 | negative regulation of epithelial cell differentiation | 3.289016e-4 |
GO:0002064 | epithelial cell development | 3.317515e-4 |
GO:0042476 | odontogenesis | 3.322572e-4 |
GO:0090184 | positive regulation of kidney development | 3.369827e-4 |
GO:0032733 | positive regulation of interleukin-10 production | 3.369827e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.436202e-4 |
GO:0032814 | regulation of natural killer cell activation | 3.602561e-4 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 3.625892e-4 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 3.681641e-4 |
GO:0007602 | phototransduction | 3.692362e-4 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 3.692826e-4 |
GO:0010002 | cardioblast differentiation | 3.732093e-4 |
GO:0010468 | regulation of gene expression | 3.740284e-4 |
GO:0032849 | positive regulation of cellular pH reduction | 3.807001e-4 |
GO:0006930 | substrate-dependent cell migration, cell extension | 3.814006e-4 |
GO:0009887 | organ morphogenesis | 3.831082e-4 |
GO:0045652 | regulation of megakaryocyte differentiation | 3.859559e-4 |
GO:0065001 | specification of axis polarity | 3.880032e-4 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.999995e-4 |
GO:0031589 | cell-substrate adhesion | 4.055570e-4 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.064439e-4 |
GO:0051145 | smooth muscle cell differentiation | 4.087741e-4 |
GO:0006325 | chromatin organization | 4.107729e-4 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4.256006e-4 |
GO:0045619 | regulation of lymphocyte differentiation | 4.382287e-4 |
GO:2000319 | regulation of T-helper 17 cell differentiation | 4.425905e-4 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 4.425905e-4 |
GO:0050708 | regulation of protein secretion | 4.426308e-4 |
GO:0072289 | metanephric nephron tubule formation | 4.437264e-4 |
GO:0045844 | positive regulation of striated muscle tissue development | 4.515296e-4 |
GO:0003206 | cardiac chamber morphogenesis | 4.519605e-4 |
GO:0001707 | mesoderm formation | 4.528717e-4 |
GO:0010827 | regulation of glucose transport | 4.557171e-4 |
GO:0001825 | blastocyst formation | 4.593688e-4 |
GO:0048729 | tissue morphogenesis | 4.729504e-4 |
GO:0007613 | memory | 4.791444e-4 |
GO:0014041 | regulation of neuron maturation | 4.837813e-4 |
GO:0006333 | chromatin assembly or disassembly | 4.839631e-4 |
GO:0050793 | regulation of developmental process | 4.849054e-4 |
GO:0021930 | cerebellar granule cell precursor proliferation | 4.901363e-4 |
GO:0060065 | uterus development | 4.912794e-4 |
GO:0003139 | secondary heart field specification | 4.939739e-4 |
GO:0009996 | negative regulation of cell fate specification | 4.984019e-4 |
GO:0030641 | regulation of cellular pH | 5.046950e-4 |
GO:0070192 | chromosome organization involved in meiosis | 5.060562e-4 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 5.060562e-4 |
GO:0021591 | ventricular system development | 5.073999e-4 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 5.136999e-4 |
GO:0006344 | maintenance of chromatin silencing | 5.221629e-4 |
GO:0002572 | pro-T cell differentiation | 5.221629e-4 |
GO:0001654 | eye development | 5.303715e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 5.304980e-4 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 5.515674e-4 |
GO:0030903 | notochord development | 5.538242e-4 |
GO:0072074 | kidney mesenchyme development | 5.629060e-4 |
GO:0060255 | regulation of macromolecule metabolic process | 5.650502e-4 |
GO:0030220 | platelet formation | 5.749088e-4 |
GO:0006885 | regulation of pH | 5.832666e-4 |
GO:0051382 | kinetochore assembly | 6.021196e-4 |
GO:0045885 | positive regulation of survival gene product expression | 6.066120e-4 |
GO:0033364 | mast cell secretory granule organization | 6.129965e-4 |
GO:0072193 | ureter smooth muscle cell differentiation | 6.129965e-4 |
GO:0045833 | negative regulation of lipid metabolic process | 6.133944e-4 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 6.294945e-4 |
GO:0006807 | nitrogen compound metabolic process | 6.406488e-4 |
GO:0030278 | regulation of ossification | 6.516117e-4 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 6.673954e-4 |
GO:0055067 | monovalent inorganic cation homeostasis | 6.903306e-4 |
GO:0051247 | positive regulation of protein metabolic process | 6.972566e-4 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 7.049670e-4 |
GO:0032765 | positive regulation of mast cell cytokine production | 7.073715e-4 |
GO:0034635 | glutathione transport | 7.073715e-4 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 7.073715e-4 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 7.073715e-4 |
GO:2000108 | positive regulation of leukocyte apoptosis | 7.119022e-4 |
GO:0010933 | positive regulation of macrophage tolerance induction | 7.145108e-4 |
GO:0035249 | synaptic transmission, glutamatergic | 7.248982e-4 |
GO:0032231 | regulation of actin filament bundle assembly | 7.260565e-4 |
GO:0048485 | sympathetic nervous system development | 7.367455e-4 |
GO:0032835 | glomerulus development | 7.395843e-4 |
GO:0046622 | positive regulation of organ growth | 7.505068e-4 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 7.510183e-4 |
GO:0010463 | mesenchymal cell proliferation | 7.538630e-4 |
GO:0035308 | negative regulation of protein dephosphorylation | 7.561027e-4 |
GO:0072006 | nephron development | 7.563066e-4 |
GO:0048633 | positive regulation of skeletal muscle tissue growth | 7.686627e-4 |
GO:0006710 | androgen catabolic process | 7.686627e-4 |
GO:0006408 | snRNA export from nucleus | 7.686627e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 7.772234e-4 |
GO:0070244 | negative regulation of thymocyte apoptosis | 7.889696e-4 |
GO:0048484 | enteric nervous system development | 8.427370e-4 |
GO:0032754 | positive regulation of interleukin-5 production | 8.447706e-4 |
GO:0001878 | response to yeast | 8.547623e-4 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 8.586851e-4 |
GO:0045884 | regulation of survival gene product expression | 8.697315e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 8.766049e-4 |
GO:0060675 | ureteric bud morphogenesis | 8.787614e-4 |
GO:0016246 | RNA interference | 8.924349e-4 |
GO:0060037 | pharyngeal system development | 8.939281e-4 |
GO:0048635 | negative regulation of muscle organ development | 9.003004e-4 |
GO:0060931 | sinoatrial node cell development | 9.016287e-4 |
GO:0003167 | atrioventricular bundle cell differentiation | 9.016287e-4 |
GO:0006991 | response to sterol depletion | 9.016287e-4 |
GO:0031323 | regulation of cellular metabolic process | 9.037450e-4 |
GO:0001501 | skeletal system development | 9.186770e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 9.210656e-4 |
GO:0021604 | cranial nerve structural organization | 9.235239e-4 |
GO:0071103 | DNA conformation change | 9.423755e-4 |
GO:0002149 | hypochlorous acid biosynthetic process | 9.459852e-4 |
GO:0045601 | regulation of endothelial cell differentiation | 9.667625e-4 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 9.709591e-4 |
GO:0032615 | interleukin-12 production | 9.753093e-4 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 9.753093e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.787266e-4 |
GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation | 9.887858e-4 |
GO:0002883 | regulation of hypersensitivity | 9.961096e-4 |
GO:0048592 | eye morphogenesis | 9.975973e-4 |
GO:0031659 | positive regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.019346e-3 |
GO:0072012 | glomerulus vasculature development | 1.023599e-3 |
GO:0010922 | positive regulation of phosphatase activity | 1.023599e-3 |
GO:0032410 | negative regulation of transporter activity | 1.023599e-3 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 1.045320e-3 |
GO:0032847 | regulation of cellular pH reduction | 1.045320e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 1.058103e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 1.058103e-3 |
GO:0021516 | dorsal spinal cord development | 1.061229e-3 |
GO:0030219 | megakaryocyte differentiation | 1.080994e-3 |
GO:0002885 | positive regulation of hypersensitivity | 1.080994e-3 |
GO:0018022 | peptidyl-lysine methylation | 1.080994e-3 |
GO:0048333 | mesodermal cell differentiation | 1.099843e-3 |
GO:0043067 | regulation of programmed cell death | 1.103967e-3 |
GO:0007498 | mesoderm development | 1.130540e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.156328e-3 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1.156328e-3 |
GO:0003218 | cardiac left ventricle formation | 1.174361e-3 |
GO:0002031 | G-protein coupled receptor internalization | 1.174361e-3 |
GO:0060021 | palate development | 1.176904e-3 |
GO:0016070 | RNA metabolic process | 1.178622e-3 |
GO:0060051 | negative regulation of protein glycosylation | 1.184424e-3 |
GO:0021629 | olfactory nerve structural organization | 1.184424e-3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.184424e-3 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 1.184424e-3 |
GO:0019543 | propionate catabolic process | 1.184424e-3 |
GO:0002700 | regulation of production of molecular mediator of immune response | 1.195009e-3 |
GO:0010454 | negative regulation of cell fate commitment | 1.198489e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 1.216104e-3 |
GO:0071310 | cellular response to organic substance | 1.232691e-3 |
GO:0000052 | citrulline metabolic process | 1.248816e-3 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 1.265422e-3 |
GO:0061004 | pattern specification involved in kidney development | 1.265545e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 1.287428e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.294892e-3 |
GO:0045661 | regulation of myoblast differentiation | 1.319453e-3 |
GO:0060592 | mammary gland formation | 1.336922e-3 |
GO:0010921 | regulation of phosphatase activity | 1.343181e-3 |
GO:0019477 | L-lysine catabolic process | 1.352075e-3 |
GO:0021670 | lateral ventricle development | 1.356123e-3 |
GO:0060921 | sinoatrial node cell differentiation | 1.393206e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 1.412820e-3 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 1.415802e-3 |
GO:0032689 | negative regulation of interferon-gamma production | 1.438628e-3 |
GO:0000238 | zygotene | 1.445026e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 1.445026e-3 |
GO:0051054 | positive regulation of DNA metabolic process | 1.454525e-3 |
GO:0042981 | regulation of apoptosis | 1.457324e-3 |
GO:0070243 | regulation of thymocyte apoptosis | 1.469582e-3 |
GO:0060019 | radial glial cell differentiation | 1.474766e-3 |
GO:0002825 | regulation of T-helper 1 type immune response | 1.474766e-3 |
GO:0032481 | positive regulation of type I interferon production | 1.508128e-3 |
GO:0005978 | glycogen biosynthetic process | 1.509687e-3 |
GO:0043010 | camera-type eye development | 1.509696e-3 |
GO:0065004 | protein-DNA complex assembly | 1.552841e-3 |
GO:0045919 | positive regulation of cytolysis | 1.553934e-3 |
GO:0042414 | epinephrine metabolic process | 1.553934e-3 |
GO:0006550 | isoleucine catabolic process | 1.553934e-3 |